DANIELLA GREAVES: Open Payments
NPI 1285232140 · SPRINGFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 32 payments from 19 companies in 2025. Trend: 2023 $378 · 2024 $418 · 2025 $772
Food & beverage: $672Education: $100
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $137 |
| Incyte Corporation | 2 | $118 |
| ABBVIE INC. | 5 | $83 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $43 |
| Genentech USA, Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| SERVIER PHARMACEUTICALS LLC | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| GENZYME CORPORATION | 1 | $23 |
Products named: REBLOZYL, IMBRUVICA, ZYNLONTA, Tecentriq, OPDIVO, EPKINLY, Nubeqa, WAYRILZ.
Industry payments across NJ — which companies pay providers there.
